Company profile: Meretek Diagnostics
1.1 - Company Overview
Company description
- Provider of non-invasive, non-radioactive breath tests and instruments for diagnostic applications, offering BreathTek UBT and BreathTek-UBiT collection kits for qualitative detection of urease associated with Helicobacter pylori in the human stomach, supporting initial diagnosis and post-treatment monitoring of Helicobacter pylori infection.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Meretek Diagnostics
AN2 Therapeutics
HQ: United States
Website
- Description: Provider of boron chemistry–based drug discovery and clinical development for infectious diseases, including epetraborole, an oral therapy in development for chronic non-tuberculous mycobacterial lung disease targeting Mycobacterium avium complex, and conducting clinical trials to obtain regulatory approval for new medications for infectious diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AN2 Therapeutics company profile →
iosBio
HQ: United Kingdom
Website
- Description: Provider of thermally stable oral vaccine platforms and services, offering vaccine manufacturing, distribution, and delivery. Its OraPro technology uses viral vectors to deliver capsule-based vaccines to the GI tract, enabling mucosal and systemic immunity without cold-chain storage. Products include OraPro and OraPro-Covid-19, an at-home oral vaccine targeting S and N proteins.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full iosBio company profile →
ImQuest Life Sciences
HQ: China
Website
- Description: Provider of infectious disease drug development, focusing on novel targets and intervention methods to inhibit organisms, addressing unmet medical needs including HIV and hepatitis C.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ImQuest Life Sciences company profile →
Alverix
HQ: United States
Website
- Description: Provider of low-cost handheld reader devices with laboratory-grade accuracy and precision; partnering with diagnostic and OEM manufacturers to increase test accuracy, improve portability of existing tests, and develop new assays for use in physician offices and laboratory outreach.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Alverix company profile →
BioMed Diagnostics
HQ: United States
Website
- Description: Provider of highly selective pre-plated prepared media culture devices that combine inoculation, culture, transport, and result analysis to reduce lab labor and costs. Solutions span clinical, veterinary point-of-care, and industrial microbiology for environmental monitoring and compliance, including InPouch, InTray, and PCR-compatible Transit Tube.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioMed Diagnostics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Meretek Diagnostics
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Meretek Diagnostics
2.2 - Growth funds investing in similar companies to Meretek Diagnostics
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Meretek Diagnostics
4.2 - Public trading comparable groups for Meretek Diagnostics
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →